Evidence map›Paper›PMID 21788385›Full record

ArticleInfection and immunity2011

Heat-labile- and heat-stable-toxoid fusions (LTR₁₉₂G-STaP₁₃F) of human enterotoxigenic Escherichia coli elicit neutralizing antitoxin antibodies.

Mei Liu, Xiaosai Ruan, Chengxian Zhang, Steve R Lawson, David E Knudsen, James P Nataro, Donald C Robertson, Weiping Zhang

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Recent progress in enterotoxigenicInfection and immunity · 2025
    Review
  3. Article
  4. Article
  5. Evaluation of Multivalent EnterotoxigenicApplied and environmental microbiology · 2022
    Article
  6. Article
  7. Pig vaccination strategies based on enterotoxigenic Escherichia coli toxins.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Development of an enterotoxigenicHuman vaccines & immunotherapeutics · 2019
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Mei LiuVeterinary & Biomedical Sciences Department/The Center for Infectious Disease Research & Vaccinology, South Dakota State University, Brookings, SD 57006, USA.
Xiaosai Ruan
Chengxian Zhang
Steve R Lawson
David E Knudsen
James P Nataro
Donald C Robertson
Weiping Zhang
South Dakota State University · USKansas State University · USUniversity of Virginia · US

Funding

Determining vaccine candidacy of LT and STa toxoid fusions against enterotoxigeniR21AI083897 · NIAID · SOUTH DAKOTA STATE UNIVERSITY · PI ZHANG, WEIPING · 2009 to 2010
$368k
NIAID NIH HHS AI083897NIAID NIH HHS R21 AI083897
6 · The paper itself

Abstract

Enterotoxigenic Escherichia coli (ETEC) strains are a major cause of diarrheal disease in humans and animals. Adhesins and enterotoxins, including heat-labile (LT) and heat-stable (STa) toxins, are the key virulence factors. Antigenic adhesin and LT antigens have been used in developing vaccines against ETEC diarrhea. However, STa has not been included because of its poor immunogenicity and potent toxicity. Our recent study showed that porcine-type STa toxoids became immunogenic and elicited neutralizing anti-STa antibodies after being genetically fused to a full-length porcine-type LT toxoid, LT(R₁₉₂G) (W. Zhang et al., Infect. Immun. 78:316-325, 2010). In this study, we mutated human-type LT and STa genes, which are highly homologous to porcine-type toxin genes, for a full-length LT toxoid (LT(R₁₉₂)) and a full-length STa toxoid (STa(P₁₃F)) and genetically fused them to produce LT₁₉₂-STa₁₃ toxoid fusions. Mice immunized with LT₁₉₂-STa₁₃ fusion antigens developed anti-LT and anti-STa IgG (in serum and feces) and IgA antibodies (in feces). Moreover, secretory IgA antibodies from immunized mice were shown to neutralize STa and cholera toxins in T-84 cells. In addition, we fused the STa₁₃ toxoid at the N terminus and C terminus, between the A1 and A2 peptides, and between the A and B subunits of LT₁₉₂ to obtain different fusions in order to explore strategies for enhancing STa immunogenicity. This study demonstrated that human-type LT₁₉₂-STa₁₃ fusions induce neutralizing antitoxin antibodies and provided important information for developing toxoid vaccines against human ETEC diarrhea.

Indexed as

AnimalsAntibodies, BacterialAntibodies, NeutralizingBacterial ToxinsEnterotoxigenic Escherichia coliEnterotoxinsEscherichia coli InfectionsEscherichia coli ProteinsFemaleGenetic EngineeringHumansImmunizationMiceMice, Inbred BALB CRecombinant Fusion ProteinsToxoidsAntibodies, BacterialAntibodies, NeutralizingBacterial ToxinsEnterotoxinsEscherichia coli Proteinsheat-labile enterotoxin, E coliheat stable toxin (E coli)Recombinant Fusion ProteinsToxoids

Identifiers

PMID21788385
PMCPMC3187267
OpenAlexW2112702233

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.